Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ENALAPRIL TAB 5MG | 5MG | TABLET | Resolved | 2018-10-25 | 2018-12-08 | 65595 |
APO-ENALAPRIL TAB 5MG | 5MG | TABLET | Resolved | 2019-09-18 | 2019-12-19 | 94168 |
APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2020-03-27 | 2020-07-06 | 109678 |
APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2018-09-04 | 2019-05-13 | 59813 |
APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2023-05-19 | 2023-06-16 | 192815 |
APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2017-03-10 | 2017-10-11 | 311 |
APO-ERLOTINIB | 100MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74875 |
APO-ERLOTINIB | 150MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74878 |
APO-ERLOTINIB | 25MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74881 |
APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-03-05 | 2019-03-09 | 77878 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-03-05 | 2019-03-09 | 77881 |
APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-03-06 | 2019-03-09 | 77971 |
APO-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-06-26 | 2020-01-20 | 87517 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-08-28 | 2020-02-19 | 92522 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-11-30 | 2019-02-08 | 68218 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-12-12 | 2019-02-26 | 69299 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-04-13 | 2020-05-19 | 111909 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-01-08 | 2021-01-26 | 131157 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-26 | 2021-03-08 | 134814 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-08-29 | 2024-10-25 | 236243 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SOTALOL - TAB 160MG | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-SUCRALFATE - TAB 1G | 1G | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61033 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
APO-TAMOX TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-09-12 | 61050 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |